Amedeo Smart

Free Medical Literature Service

 

Amedeo

Liver Diseases
  Free Subscription

Articles published in
Dig Dis Sci
    May 2024
  1. PEMMASANI G, Tremaine W, Karagozian R, John S, et al
    Impact of Cirrhosis Etiology on the Risk for Venous Thromboembolism.
    Dig Dis Sci. 2024 May 3. doi: 10.1007/s10620-024-08440.
    >> Share

  2. THRIFT AP, Nguyen Wenker TH, Godwin K, Balakrishnan M, et al
    An Electronic Health Record Model for Predicting Risk of Hepatic Fibrosis in Primary Care Patients.
    Dig Dis Sci. 2024 May 3. doi: 10.1007/s10620-024-08437.
    >> Share

    April 2024
  3. TAN C, Zeng X, Guo X, Mo M, et al
    A Novel lncRNA lncRNA-4045 Promotes the Progression of Hepatocellular Carcinoma by Affecting the Expression of AKR1B10.
    Dig Dis Sci. 2024 Apr 25. doi: 10.1007/s10620-024-08383.
    >> Share

  4. MARCANTEI C, Couret A, King J, Mazeaud S, et al
    Effects of Exercise Training on Muscle Mass and Physical Function in Patients with Hepatocellular Carcinoma After Diagnosis: A Systematic Review.
    Dig Dis Sci. 2024 Apr 25. doi: 10.1007/s10620-024-08441.
    >> Share

  5. HSIEH HC, Chang WP, Huang PJ, Wang CH, et al
    Effectiveness of Exercise Interventions on Body Composition, Exercise Capacity, Fatigue, and Quality of Life in Patients with Liver Cirrhosis: A Meta-Analysis of Randomized Controlled Trials.
    Dig Dis Sci. 2024 Apr 24. doi: 10.1007/s10620-024-08447.
    >> Share

  6. HORBAL SR, Belancourt PX, Zhang P, Holcombe SA, et al
    Independent Associations of Aortic Calcification with Cirrhosis and Liver Related Mortality in Veterans with Chronic Liver Disease.
    Dig Dis Sci. 2024 Apr 23. doi: 10.1007/s10620-024-08450.
    >> Share

  7. CHANG ML, Le PH, Chen WT, Chen TD, et al
    Hepatic and Extrahepatic Characteristics of Autoimmune Hepatitis: A 23-year Hospital-Based Cohort Study.
    Dig Dis Sci. 2024 Apr 23. doi: 10.1007/s10620-024-08439.
    >> Share

  8. ZHANG X, Wang W, Mo S, Sun X, et al
    DEAD-Box Helicase 17 circRNA (circDDX17) Reduces Sorafenib Resistance and Tumorigenesis in Hepatocellular Carcinoma.
    Dig Dis Sci. 2024 Apr 23. doi: 10.1007/s10620-024-08401.
    >> Share

  9. MOON AM, Swier RM, Lane LM, Barritt AS 4th, et al
    Statewide Survey of Primary Care and Subspecialty Providers on Hepatocellular Carcinoma Risk-Stratification and Surveillance Practices.
    Dig Dis Sci. 2024 Apr 23. doi: 10.1007/s10620-024-08442.
    >> Share

  10. MANNING ME, Fricker Z
    Cardiopulmonary Resuscitation Outcomes and Trainee Perception of Code Status Discussions in Patients with Cirrhosis.
    Dig Dis Sci. 2024 Apr 23. doi: 10.1007/s10620-024-08443.
    >> Share

  11. TWOHIG PA, Peeraphatdit TB, Samson K, Schissel M, et al
    A Prospective Multimodal Education Intervention for Providers Does Not Increase Hepatic Encephalopathy Treatment Rates.
    Dig Dis Sci. 2024 Apr 23. doi: 10.1007/s10620-024-08445.
    >> Share

  12. WEBER S, Unger K, Alunni-Fabbroni M, Hirner-Eppeneder H, et al
    Metabolomic Analysis of Human Cirrhosis and Hepatocellular Carcinoma: A Pilot Study.
    Dig Dis Sci. 2024 Apr 23. doi: 10.1007/s10620-024-08446.
    >> Share

  13. MCCURDY H, Nobbe A, Scott D, Patton H, et al
    Organizational and Implementation Factors Associated with Cirrhosis Care in the Veterans Health Administration.
    Dig Dis Sci. 2024 Apr 14. doi: 10.1007/s10620-024-08409.
    >> Share

  14. PEARLMAN BL
    Direct-Acting Antiviral Therapy for Patients with Chronic Hepatitis C Infection and Decompensated Cirrhosis.
    Dig Dis Sci. 2024 Apr 5. doi: 10.1007/s10620-024-08393.
    >> Share

  15. KHAMSEH ME, Malek M, Jahangiri S, Nobarani S, et al
    Insulin Resistance/Sensitivity Measures as Screening Indicators of Metabolic-Associated Fatty Liver Disease and Liver Fibrosis.
    Dig Dis Sci. 2024;69:1430-1443.
    >> Share

  16. POP A, Halegoua-DeMarzio D, Barnhart H, Kleiner D, et al
    Amiodarone and Dronedarone Causes Liver Injury with Distinctly Different Clinical Presentations.
    Dig Dis Sci. 2024;69:1479-1487.
    >> Share

  17. WILLIAMS EE, Mladenovic A, Ranginani D, Weber R, et al
    Role of Spleen Stiffness Measurement in the Evaluation of Metabolic Dysfunction-Associated Steatotic Liver Disease.
    Dig Dis Sci. 2024;69:1444-1453.
    >> Share

  18. BEHARI J
    Spleen Stiffness Measurement in Metabolic Dysfunction-Associated Steatotic Liver Disease-Value Added or Work in Progress?
    Dig Dis Sci. 2024;69:1093-1095.
    >> Share

    March 2024
  19. WANG H, Liu X, Xie Y, Qin X, et al
    A Case of Immunoglobulin Light Chain Hepatic Amyloidosis with Abdominal Hematoma.
    Dig Dis Sci. 2024 Mar 30. doi: 10.1007/s10620-024-08342.
    >> Share

  20. JAFRI F, Saad S, Riaz H, Saleem F, et al
    Lack of Diversity in Transplant Hepatology Fellowship Program Directorship.
    Dig Dis Sci. 2024 Mar 23. doi: 10.1007/s10620-024-08388.
    >> Share

  21. ARSHAD T, Vainer D, Khan H, Baral A, et al
    Development of Clinical Algorithm Utilizing Vibration-Controlled Transient Elastography to Detect Advanced Hepatic Fibrosis in Liver Transplant Recipients.
    Dig Dis Sci. 2024 Mar 18. doi: 10.1007/s10620-024-08366.
    >> Share

  22. KAHN-BOESEL O, Mitchell H, Li L, Zhu E, et al
    Hospital-Level Care at Home for Patients with Cirrhosis.
    Dig Dis Sci. 2024 Mar 11. doi: 10.1007/s10620-024-08361.
    >> Share

  23. PETROSYAN R, Endres P, Ufere NN, St Hillien SA, et al
    Healthcare Resource Utilization and Goals of Care Discussions in Patients with Cirrhosis and Acute Kidney Injury.
    Dig Dis Sci. 2024 Mar 7. doi: 10.1007/s10620-024-08317.
    >> Share

  24. PATEL AA, Walling A, Bansal A
    A New Look at Goals-of-Care Discussions in Patients with Cirrhosis and Acute Kidney Injury.
    Dig Dis Sci. 2024 Mar 7. doi: 10.1007/s10620-024-08300.
    >> Share

  25. REN J, Yao X, Yang M, Cheng S, et al
    Kinesin Family Member-18A (KIF18A) Promotes Cell Proliferation and Metastasis in Hepatocellular Carcinoma.
    Dig Dis Sci. 2024 Mar 6. doi: 10.1007/s10620-024-08321.
    >> Share

  26. KIM RG, Patel S, Satre DD, Shumway M, et al
    Telehepatology Satisfaction Is Associated with Ethnicity: The Real-World Experience of a Vulnerable Population with Fatty Liver Disease.
    Dig Dis Sci. 2024;69:732-742.
    >> Share

  27. JAROENLAPNOPPARAT A, Mettler SK, Guillen H, Chayanupatkul M, et al
    Changes in the Prevalence, Incidence, and Disability-Adjusted Life Years of Non-alcoholic Fatty Liver Disease in the United States Between 1990 and 2019.
    Dig Dis Sci. 2024;69:702-712.
    >> Share

  28. VASSILOPOULOS A, Kalligeros M, Vassilopoulos S, Shehadeh F, et al
    Prevalence of Steatotic Liver Disease Among US Adults with Rheumatoid Arthritis.
    Dig Dis Sci. 2024;69:989-1003.
    >> Share

  29. SADLIK G, Anderson RC, Lei X, Cen SY, et al
    Pseudocirrhosis: A Case Series with Clinical and Radiographic Correlation and Review of the Literature.
    Dig Dis Sci. 2024;69:1004-1014.
    >> Share

    February 2024
  30. KALAITZAKIS ZE, Giahnakis E, Koutroubakis IE, Mouzas IA, et al
    Bariatric Nutritional Intervention in Obese Patients with Compensated Liver Cirrhosis: A Four-Year Prospective Study.
    Dig Dis Sci. 2024 Feb 27. doi: 10.1007/s10620-023-08223.
    >> Share

  31. ZHAO X, Guo X, Zhao Y, Yu Y, et al
    Gastrointestinal Bleeding Was Diagnosed as Small Intestinal Metastasis of Hepatocellular Carcinoma by Double-Balloon Enteroscopy.
    Dig Dis Sci. 2024 Feb 21. doi: 10.1007/s10620-024-08339.
    >> Share

  32. YE N, Shi X, Gao J, Dong R, et al
    Exosomes from Intrahepatic Cholestasis of Pregnancy Induce Cell Apoptosis Through the miRNA-6891-5p/YWHAE Pathway.
    Dig Dis Sci. 2024 Feb 15. doi: 10.1007/s10620-023-08265.
    >> Share

  33. GU Y, Chen G, Ning X
    Homeobox Protein BarH-like 1 Promotes Gastric Cancer Progression by Activating Coiled-Coil Domain-Containing Protein 178.
    Dig Dis Sci. 2024 Feb 15. doi: 10.1007/s10620-024-08312.
    >> Share

  34. ARE VS, Gromski MA, Akisik F, Vilar-Gomez E, et al
    Primary Sclerosing Cholangitis Limited to Intrahepatic Bile Ducts Has Distinctly Better Prognosis.
    Dig Dis Sci. 2024 Feb 12. doi: 10.1007/s10620-023-08260.
    >> Share

  35. MUKUND A, Aravind A, Jindal A, Tevethia HV, et al
    Predictors and Outcomes of Post-transjugular Intrahepatic Portosystemic Shunt Liver Failure in Patients with Cirrhosis.
    Dig Dis Sci. 2024 Feb 10. doi: 10.1007/s10620-023-08256.
    >> Share

  36. YILMAZ L, Bulut A, Aytekin A, Baskonus I, et al
    A Novel Technique for the Management of Persistent Biliary Fistulas Developing After Liver Hydatid Cyst Surgeries: Drain Clamping Technique.
    Dig Dis Sci. 2024 Feb 10. doi: 10.1007/s10620-024-08284.
    >> Share

  37. LI R, Sarin S
    Disparity Among African Americans in Transjugular Intrahepatic Portosystemic Shunt Procedure: A National Inpatient Sample Analysis from 2015 to 2020.
    Dig Dis Sci. 2024 Feb 6. doi: 10.1007/s10620-024-08273.
    >> Share

  38. BATSAIKHAN B, Dai CY
    Treatment of Hepatocellular Carcinoma in the Elderly: Slash or Burn?
    Dig Dis Sci. 2024 Feb 1. doi: 10.1007/s10620-023-08247.
    >> Share

  39. KIM JI, Lee J, Choi GH, Lee MW, et al
    Comparison of Surgical Resection and Radiofrequency Ablation in Elderly Patients with Hepatocellular Carcinoma.
    Dig Dis Sci. 2024 Feb 1. doi: 10.1007/s10620-023-08245.
    >> Share

  40. ZEREM E, Denjagic Basic M, Kurtcehajic A, Zerem D, et al
    Indications for the Use of Endoscopic Ultrasound-Guided Liver Biopsy in Patients with Liver Fibrosis.
    Dig Dis Sci. 2024;69:643-644.
    >> Share

  41. ASHKTORAB H, Challa SR, Singh G, Nanduri S, et al
    Gastrointestinal Manifestations and Their Association with Neurologic and Sleep Problems in Long COVID-19 Minority Patients: A Prospective Follow-Up Study.
    Dig Dis Sci. 2024;69:562-569.
    >> Share

  42. WAJSBROT NB, Leite NC, Franca PHC, Cardoso CRL, et al
    Parental History of Type 2 Diabetes Mellitus and PNPLA3 Polymorphism Increase the Risk of Severe Stages of Nonalcoholic Fatty Liver Disease.
    Dig Dis Sci. 2024;69:634-642.
    >> Share

  43. FIGUEROA G, Castaneda S, McLean H, Dukandar J, et al
    Low Health Literacy, Lack of Knowledge, and Self-Control Hinder Healthy Lifestyles in Diverse Patients with Steatotic Liver Disease.
    Dig Dis Sci. 2024;69:384-398.
    >> Share

  44. BEHARI J, Bradley A, Townsend K, Becich MJ, et al
    Limitations of Noninvasive Tests-Based Population-Level Risk Stratification Strategy for Nonalcoholic Fatty Liver Disease.
    Dig Dis Sci. 2024;69:370-383.
    >> Share

    January 2024
  45. HUANG FD, Zhong YP, Sun GY, Xu QJ, et al
    Fanconi Anemia Complementary Group A (FANCA) Facilitates the Occurrence and Progression of Liver Hepatocellular Carcinoma.
    Dig Dis Sci. 2024 Jan 28. doi: 10.1007/s10620-024-08282.
    >> Share

  46. ASADA S, Namisaki T, Kaji K, Takaya H, et al
    VWF/ADAMTS13 Ratio as a Potential Predictive Biomarker for Acute Kidney Injury Onset in Cirrhosis.
    Dig Dis Sci. 2024 Jan 20. doi: 10.1007/s10620-023-08257.
    >> Share

  47. BOWMAN CA, Bichoupan K, Posner S, Schonfeld E, et al
    A Prospective Open-Label Dose-Response Study to Correct Vitamin D Deficiency in Cirrhosis.
    Dig Dis Sci. 2024 Jan 13. doi: 10.1007/s10620-023-08224.
    >> Share

  48. TSAI SY, O'Leary JG
    Optimizing Outcomes in Patients with Ascites Complicating Cirrhosis-Maximizing the Hour of Power.
    Dig Dis Sci. 2024 Jan 13. doi: 10.1007/s10620-023-08255.
    >> Share

  49. BADAL J, Badal B, Nawras M, Lee-Smith W, et al
    Diagnostic Paracentesis Within 1 Day Is Associated With Reduced Mortality and Length of Hospital Stay in Patients with Cirrhosis and Ascites.
    Dig Dis Sci. 2024 Jan 13. doi: 10.1007/s10620-023-08249.
    >> Share

  50. LIN W, Zhao Z, Du W, Ni Z, et al
    Interferon-Gamma-Inducible Protein 16 Inhibits Hepatocellular Carcinoma via Interferon Regulatory Factor 3 on Chemosensitivity.
    Dig Dis Sci. 2024 Jan 3. doi: 10.1007/s10620-023-08175.
    >> Share

  51. BLOOM PP, Che Z, Hyde A, Johnson E, et al
    Development and Evaluation of a Patient Cirrhosis Knowledge Assessment.
    Dig Dis Sci. 2024 Jan 3. doi: 10.1007/s10620-023-08238.
    >> Share

    December 2023
  52. JAMES M, Alazawi W
    Non-invasive Tests of Fibrosis: Does One Size Fit All?
    Dig Dis Sci. 2023;68:4285-4286.
    >> Share

  53. ARORA U, Goyal RM, Teh KKJ, Pei Y, et al
    Poor Performance of Non-invasive Tests for Advanced Fibrosis in Nonalcoholic Fatty Liver Disease: A Multicentric Asian Study.
    Dig Dis Sci. 2023;68:4485-4498.
    >> Share

    November 2023
  54. SUN Y, Lu M, Feldman R, Saul M, et al
    Positive Predictive Value of Cirrhosis and Chronic Pancreatitis Diagnoses in Individuals with Alcohol Use Disorder: A Single-Center Study.
    Dig Dis Sci. 2023 Nov 29. doi: 10.1007/s10620-023-08183.
    >> Share

  55. SOHAL A, Kohli I, Chaudhry H, Singh I, et al
    Vaccine-Preventable Illness Leads to Adverse Outcomes in Liver Transplant Recipients.
    Dig Dis Sci. 2023 Nov 29. doi: 10.1007/s10620-023-08202.
    >> Share

  56. WONG ZY, Koh JH, Muthiah M, Koh B, et al
    Proton Pump Inhibitors Increases Longitudinal Risk of Mortality, Decompensation, and Infection in Cirrhosis: A Meta-Analysis.
    Dig Dis Sci. 2023 Nov 15. doi: 10.1007/s10620-023-08150.
    >> Share

  57. LOW EXS, Wang YP, Lu CL
    Risks of Proton Pump Inhibitors in Patients with Cirrhosis: Please Peruse the Indications.
    Dig Dis Sci. 2023 Nov 15. doi: 10.1007/s10620-023-08153.
    >> Share

    October 2023
  58. JINDAL A, Sharma MK, Vijayaraghavan R, Sm S, et al
    Severity of Acute Portal Hypertension Determines the Clinical Outcomes in Severe Alcoholic Hepatitis.
    Dig Dis Sci. 2023 Oct 31. doi: 10.1007/s10620-023-08144.
    >> Share

  59. GONZALEZ HC, Trudeau S
    COVID-19 + Cirrhosis = Excess Hospital Confinement, Excess Casualties.
    Dig Dis Sci. 2023 Oct 21. doi: 10.1007/s10620-023-08106.
    >> Share

  60. TWOHIG PA, Scholten K, Schissel M, Brittan K, et al
    Mortality Increased Among Hospitalized Patients with Cirrhosis Before and Following Different Waves of the COVID-19 Pandemic.
    Dig Dis Sci. 2023 Oct 21. doi: 10.1007/s10620-023-08105.
    >> Share

  61. BANGARU S, Sundaresh R, Lee A, Prause N, et al
    Predictive Algorithm for Hepatic Steatosis Detection Using Elastography Data in the Veterans Affairs Electronic Health Records.
    Dig Dis Sci. 2023 Oct 21. doi: 10.1007/s10620-023-08043.
    >> Share

  62. KILANI Y, Kamal SAF, Vikash F, Vikash S, et al
    Correction to: Racial Disparities in Liver Transplantation for Hepatocellular Carcinoma in the United States: An Update.
    Dig Dis Sci. 2023 Oct 13. doi: 10.1007/s10620-023-08131.
    >> Share

  63. WANG L, Zhang Y, Li J, Guo S, et al
    A Nomogram of Magnetic Resonance Imaging for Preoperative Assessment of Microvascular Invasion and Prognosis of Hepatocellular Carcinoma.
    Dig Dis Sci. 2023 Oct 4. doi: 10.1007/s10620-023-08022.
    >> Share

  64. DAKROUB A, Anouti A, Cotter TG, Lee WM, et al
    Mortality and Morbidity Among Adult Liver Retransplant Recipients.
    Dig Dis Sci. 2023;68:4039-4049.
    >> Share

  65. KAUR P, Verma N, Valsan A, Garg P, et al
    Prevalence, Risk Factors, and Impact of Bacterial or Fungal Infections in Acute Liver Failure Patients from India.
    Dig Dis Sci. 2023;68:4022-4038.
    >> Share

  66. SMAYRA K, Miangul S, Yap N, Shi A, et al
    Technical Success, Sample Adequacy, and Complications of Pediatric Transjugular Liver Biopsy: A Systematic Review and Meta-Analysis.
    Dig Dis Sci. 2023;68:3846-3856.
    >> Share

  67. LI R, Li M, Bidulescu A, Fly AD, et al
    Diets with Higher Anti-inflammatory Potential Associated with Lower Risk of Development of Nonalcoholic Fatty Liver Disease and Early-Stage of Fibrosis Among US Adults.
    Dig Dis Sci. 2023;68:4009-4021.
    >> Share

    September 2023
  68. GOBLE S, Akambase J, Prieto J, Balderramo D, et al
    MBOAT7 rs641738 Variant Is Not Associated with an Increased Risk of Hepatocellular Carcinoma in a Latin American Cohort.
    Dig Dis Sci. 2023 Sep 8. doi: 10.1007/s10620-023-08104.
    >> Share

  69. CHOI AY, Li X, Guo W, Chandan VS, et al
    Performance of Endoscopic Ultrasound-Guided Versus Percutaneous Liver Biopsy in Diagnosing Stage 3-4 Fibrosis.
    Dig Dis Sci. 2023;68:3774-3780.
    >> Share

  70. MCNALLY BB, Rangan P, Wijarnpreecha K, Fallon MB, et al
    Fibrosis-4 Index Score Predicts Concomitant Coronary Artery Diseases Across the Spectrum of Fatty Liver Disease.
    Dig Dis Sci. 2023;68:3765-3773.
    >> Share

    August 2023
  71. KILANI Y, Kamal SAF, Vikash F, Vikash S, et al
    Racial Disparities in Liver Transplantation for Hepatocellular Carcinoma in the United States: An Update.
    Dig Dis Sci. 2023 Aug 16. doi: 10.1007/s10620-023-08084.
    >> Share

    July 2023
  72. TAPPER EB, Saleh ZM, Lizza S, Chen X, et al
    CAREGIVER Randomized Trial of Two Mindfulness Methods to Improve the Burden and Distress of Caring for Persons with Cirrhosis.
    Dig Dis Sci. 2023 Jul 27. doi: 10.1007/s10620-023-08042.
    >> Share

  73. ROY S, Mewara A, Gupta R, Rana SS, et al
    Endoscopic Diagnosis of Biliary Fascioliasis in Non-endemic Region.
    Dig Dis Sci. 2023 Jul 27. doi: 10.1007/s10620-023-08045.
    >> Share

  74. SUAREZ M, Martinez R, Torres AM, Torres B, et al
    A Machine Learning Method to Identify the Risk Factors for Liver Fibrosis Progression in Nonalcoholic Steatohepatitis.
    Dig Dis Sci. 2023 Jul 21. doi: 10.1007/s10620-023-08031.
    >> Share

  75. THANAKUNCHAI T, Hongthanakorn C
    Prevalence and Risk Factors of Post-chemoembolization Syndrome After Chemo-Embolization for Hepatocellular Carcinoma in Thailand.
    Dig Dis Sci. 2023 Jul 4. doi: 10.1007/s10620-023-08010.
    >> Share

  76. MOORE JA, Wheless WH, Zhang J, Marsden J, et al
    Gaps in Confirmatory Fibrosis Risk Assessment in Primary Care Patients with Nonalcoholic Fatty Liver Disease.
    Dig Dis Sci. 2023;68:2946-2953.
    >> Share

  77. BROWN C, Aksan N, Chang P, Jagannathan P, et al
    Delayed Diagnostic Paracentesis Is Associated with Increased Preventable Healthcare Utilization in Disadvantaged Patient Populations with Advanced Liver Disease and Elevated INR.
    Dig Dis Sci. 2023;68:2954-2962.
    >> Share

    June 2023
  78. WENTWORTH BJ, Khot R, Caldwell SH
    The Many Faces of Primary Sclerosing Cholangitis: Controversy Abounds.
    Dig Dis Sci. 2023 Jun 26. doi: 10.1007/s10620-023-08003.
    >> Share

  79. ATTANASI ML, Bou Daher H, Rockey DC
    Natural History and Outcomes of Cavernous Transformation of the Portal Vein in Cirrhosis.
    Dig Dis Sci. 2023 Jun 22. doi: 10.1007/s10620-023-07993.
    >> Share

  80. ALUKAL JJ, Li F, Thuluvath PJ
    Liver Transplantation Within 7-Days of Listing Improves Survival in ACLF-3.
    Dig Dis Sci. 2023 Jun 21. doi: 10.1007/s10620-023-08011.
    >> Share

  81. MCHENRY S, Awad A, Kozlitina J, Stitziel NO, et al
    Low LDL Cholesterol Is Not an Independent Risk Factor for Hepatic Steatosis.
    Dig Dis Sci. 2023 Jun 8. doi: 10.1007/s10620-023-07980.
    >> Share

  82. OBRI MS, Youssef RM, Alluri S, Vemulapalli K, et al
    Disparities in Referrals to End-of-Life Care in Eligible Hepatocellular Carcinoma Patients.
    Dig Dis Sci. 2023 Jun 8. doi: 10.1007/s10620-023-07992.
    >> Share

  83. CHENG KL, Cheng YM, Chan CY, Wang CC, et al
    Predictors of Liver Dysfunction After Transhepatic Arterial Chemo-embolization in Hepatocellular Carcinoma Patients.
    Dig Dis Sci. 2023 Jun 2. doi: 10.1007/s10620-023-07984.
    >> Share

  84. BOU DAHER H, Manka P, Syn WK
    Settling the Score: Which Fibrosis Screening Tool Is the Most Reliable for Nonalcoholic Fatty Liver Disease?
    Dig Dis Sci. 2023;68:2217-2220.
    >> Share

  85. BERTOT LC, Jeffrey GP, de Boer B, Wang Z, et al
    Comparative Accuracy of Clinical Fibrosis Markers, Hepascore and Fibroscan(R) to Detect Advanced Fibrosis in Patients with Nonalcoholic Fatty Liver Disease.
    Dig Dis Sci. 2023;68:2757-2767.
    >> Share

    May 2023
  86. MUNOZ AE, Pollarsky F, Marino M, Cartier M, et al
    Baseline Severity and Inflammation Would Influence the Effect of Simvastatin on Clinical Outcomes in Cirrhosis Patients.
    Dig Dis Sci. 2023 May 22. doi: 10.1007/s10620-023-07969.
    >> Share

  87. KAPLAN DE
    Statins in Cirrhosis: Trial Data Are in but the Jury Is Still Out.
    Dig Dis Sci. 2023 May 22. doi: 10.1007/s10620-023-07970.
    >> Share

  88. MUKUND A, Marri UK, Jindal A, Choudhury A, et al
    Safety and Efficacy of Transjugular Intrahepatic Portosystemic Shunt for Non-tumoral Cirrhotic Portal Vein Thrombosis Not Responding to Anticoagulation Therapy.
    Dig Dis Sci. 2023 May 12. doi: 10.1007/s10620-023-07930.
    >> Share

  89. SANDHU S, John BV
    Spontaneous Bacterial Peritonitis: The Bug Matters.
    Dig Dis Sci. 2023;68:1667-1669.
    >> Share

  90. FUREY C, Zhou S, Park JH, Foong A, et al
    Impact of Bacteria Types on the Clinical Outcomes of Spontaneous Bacterial Peritonitis.
    Dig Dis Sci. 2023;68:2140-2148.
    >> Share

  91. DEVARBHAVI H, Sridhar A, Kurien SS, Gowda V, et al
    Clinical and Liver Biochemistry Phenotypes, and Outcome in 133 Patients with Anti-seizure Drug-Induced Liver Injury.
    Dig Dis Sci. 2023;68:2099-2106.
    >> Share

    April 2023
  92. CHOW KW, Ibrahim BM, Yum JJ, Dang A, et al
    Barriers to Lactulose Adherence in Patients with Cirrhosis and Hepatic Encephalopathy.
    Dig Dis Sci. 2023 Apr 29. doi: 10.1007/s10620-023-07935.
    >> Share

  93. RUSTAM LB, Vander Weg M, Chrischilles E, Tanaka T, et al
    Sociodemographic and Clinical Factors Associated with Nonattendance at the Hepatology Clinic.
    Dig Dis Sci. 2023 Apr 27. doi: 10.1007/s10620-023-07951.
    >> Share

  94. GARG R, Mohammed A, Singh A, Siddiki H, et al
    Mortality Trends, Outcomes, and Predictors of Portal Vein Thrombosis in Acute Pancreatitis Patients: A Propensity-Matched National Study.
    Dig Dis Sci. 2023 Apr 25. doi: 10.1007/s10620-023-07945.
    >> Share

  95. PATERNOSTRO R
    Muscle Mass Effect: The Importance of Diagnosing and Treating Sarcopenia in Patients with Advanced Chronic Liver Disease.
    Dig Dis Sci. 2023;68:1089-1090.
    >> Share

  96. UNALP-ARIDA A, Ruhl CE
    Prepandemic Prevalence Estimates of Fatty Liver Disease and Fibrosis Defined by Liver Elastography in the United States.
    Dig Dis Sci. 2023;68:1237-1252.
    >> Share

  97. MAHMUD N, Reddy KR, Taddei TH, Kaplan DE, et al
    Type of Infection Is Associated with Prognosis in Acute-on-Chronic Liver Failure: A National Veterans Health Administration Study.
    Dig Dis Sci. 2023;68:1632-1640.
    >> Share

    March 2023
  98. ZHI SC, Chen SZ, Li YY, Li JJ, et al
    Retraction Note: Rosiglitazone Inhibits Activation of Hepatic Stellate Cells via Up-Regulating Micro-RNA-124-3p to Alleviate Hepatic Fibrosis.
    Dig Dis Sci. 2023 Mar 29. doi: 10.1007/s10620-023-07926.
    >> Share

  99. PROTOPAPAS AA, Savopoulos C, Skoura L, Goulis I, et al
    Anticoagulation in Patients with Liver Cirrhosis: Friend or Foe?
    Dig Dis Sci. 2023 Mar 24. doi: 10.1007/s10620-023-07858.
    >> Share

  100. SMITH HT, de Souza AR, Thompson AH, McLaughlin MM, et al
    Cholestatic Pruritus Treatments in Primary Biliary Cholangitis and Primary Sclerosing Cholangitis: A Systematic Literature Review.
    Dig Dis Sci. 2023 Mar 18:1-21. doi: 10.1007/s10620-023-07862.
    >> Share

  101. GOODMAN MC, Chesner JH, Pourmand K, Farouk SS, et al
    Developing a Novel Case-Based Gastroenterology/Hepatology Online Resource for Enhanced Education During and After the COVID-19 Pandemic.
    Dig Dis Sci. 2023 Mar 15. doi: 10.1007/s10620-023-07910.
    >> Share

  102. KHALIFA A, Obeid JS, Gregoski MJ, Rockey DC, et al
    Accurate Identification of Patients with Cirrhosis and Its Complications in the Electronic Health Record.
    Dig Dis Sci. 2023 Mar 10. doi: 10.1007/s10620-023-07876.
    >> Share

  103. JAFRI FI, de Montfort Shepherd A, Raman P, Varkey TC, et al
    Transplant Hepatology Fellowship Websites: The Good, the Bad, and the Unhelpful.
    Dig Dis Sci. 2023 Mar 7:1-5. doi: 10.1007/s10620-023-07887.
    >> Share

  104. JAMMA T
    SALL4 Expression in Epithelial Gastric Cancer: Epigenetic or Epiphenomenon?
    Dig Dis Sci. 2023 Mar 6. doi: 10.1007/s10620-022-07791.
    >> Share

  105. CALMET FH, Martin P
    Acid Test: MELD-Lactate Enhances Prediction in Patients with Variceal Hemorrhage.
    Dig Dis Sci. 2023;68:723-724.
    >> Share

  106. SINGAL AG, Parikh ND, Hoshida Y
    Precision HCC Surveillance: It Is All in the Number (Needed).
    Dig Dis Sci. 2023;68:720-722.
    >> Share

  107. AGGARWAL M, Garg R, Parthasarthy G, Nowacki AS, et al
    Crohn's Disease Is Associated with Liver Fibrosis in Patients with Nonalcoholic Fatty Liver Disease.
    Dig Dis Sci. 2023;68:1006-1015.
    >> Share

  108. ELHENCE A, Anand A, Biswas S, Vaishnav M, et al
    Compensated Advanced Chronic Liver Disease in Nonalcoholic Fatty Liver Disease: Two-Step Strategy is Better than Baveno Criteria.
    Dig Dis Sci. 2023;68:1016-1025.
    >> Share

    February 2023
  109. YANG Y, Sun JH, Tan XY, Lu CD, et al
    MTM-HCC at Previous Liver Resection as a Predictor of Overall Survival in Salvage Liver Transplantation.
    Dig Dis Sci. 2023 Feb 15. doi: 10.1007/s10620-023-07857.
    >> Share

  110. DUKEWICH M, Liu CH, Weinberg EM, Mahmud N, et al
    Clinical Predictors of Intensive Care Unit Transfer in Admitted Patients with Cirrhosis.
    Dig Dis Sci. 2023 Feb 12. doi: 10.1007/s10620-023-07856.
    >> Share

  111. SHEN S, Huang H, Wang J, Tang Z, et al
    Positive Association Between the Chinese Visceral Adiposity Index and Nonalcoholic Fatty Liver Disease in Lean Adults.
    Dig Dis Sci. 2023;68:656-664.
    >> Share

  112. ISLAM KB, Brandman D, Chu JN, Goldman ML, et al
    Primary Care Providers and Nonalcoholic Fatty Liver Disease: A Needs Assessment Survey.
    Dig Dis Sci. 2023;68:434-438.
    >> Share

  113. LV L, Wang D, Yin J, Yang T, et al
    Downregulation of miR-20b-5p Contributes to the Progression of Liver Fibrosis via the STAT3 Signaling Pathway In Vivo and In Vitro.
    Dig Dis Sci. 2023;68:487-496.
    >> Share

  114. KHAN S, Kalkwarf HJ, Hornung L, Siegel R, et al
    Histologic Severity of Nonalcoholic Fatty Liver Disease Associates with Reduced Bone Mineral Density in Children.
    Dig Dis Sci. 2023;68:644-655.
    >> Share

    January 2023
  115. SONG J, Wang X, Yan Y, Xiang T, et al
    MELD 3.0 Score for Predicting Survival in Patients with Cirrhosis After Transjugular Intrahepatic Portosystemic Shunt Creation.
    Dig Dis Sci. 2023 Jan 30. doi: 10.1007/s10620-023-07834.
    >> Share

  116. DAHMUS J, Hummer B, Rivas G, Schmitz K, et al
    Patients with Nonalcoholic Steatohepatitis and Advanced Liver Disease Have the Lowest Cardiorespiratory Fitness.
    Dig Dis Sci. 2023 Jan 24. doi: 10.1007/s10620-022-07809.
    >> Share

  117. LI H, Lan H, Zhang M, Zhao F, et al
    TEA Domain Transcription Factor 1 Inhibits Ferroptosis and Sorafenib Sensitivity of Hepatocellular Carcinoma Cells.
    Dig Dis Sci. 2023 Jan 21. doi: 10.1007/s10620-023-07824.
    >> Share

    December 2022
  118. LI T, Liu J, Zhao J, Bai Y, et al
    Sarcopenia Defined by Psoas Muscle Thickness Predicts Mortality After Transjugular Intrahepatic Portosystemic Shunt.
    Dig Dis Sci. 2022 Dec 30. doi: 10.1007/s10620-022-07806.
    >> Share

  119. WANG H, Chen W, Qi Y, Liu D, et al
    miR-29c Suppresses the Malignant Phenotype of Hepatocellular Carcinoma Cells In Vitro by Mediating TPX2 Associated with Immune Infiltration.
    Dig Dis Sci. 2022 Dec 30. doi: 10.1007/s10620-022-07810.
    >> Share

  120. RUDNICK SR, Ugwuegbu J, Soufleris SJ, Bundy R, et al
    Telephone-Only Visits Preserved Hepatocellular Cancer Screening Rates in Patients with Cirrhosis Early in the COVID-19 Pandemic.
    Dig Dis Sci. 2022 Dec 23. doi: 10.1007/s10620-022-07786.
    >> Share

  121. JINDAL A, Agarwal S, Sharma S, Kumar M, et al
    Assessment of the Performance of Non-invasive Criteria for the Evaluation of Clinically Significant Portal Hypertension in Patients with Compensated Advanced Chronic Liver Disease.
    Dig Dis Sci. 2022 Dec 23. doi: 10.1007/s10620-022-07778.
    >> Share

  122. WANG ZJ, Lv XH, Yang JL
    Methodological Issues to Be Considered in Evaluating Advanced Endoscopic Resection Techniques in Cirrhosis.
    Dig Dis Sci. 2022 Dec 20. doi: 10.1007/s10620-022-07767.
    >> Share

  123. KEATING SE, Croci I, Wallen MP, Cox ER, et al
    High-Intensity Interval Training is Safe, Feasible and Efficacious in Nonalcoholic Steatohepatitis: A Randomized Controlled Trial.
    Dig Dis Sci. 2022 Dec 20:1-17. doi: 10.1007/s10620-022-07779.
    >> Share

    November 2022
  124. CHENG S, Yu E, Garacci Z, Erwin AL, et al
    Prevalence of Undiagnosed Acute Hepatic Porphyria in Cyclic Vomiting Syndrome and Overlap in Clinical Symptoms.
    Dig Dis Sci. 2022 Nov 16. pii: 10.1007/s10620-022-07756.
    >> Share

  125. HORVATITS T, Mahmud N, Serper M, Seiz O, et al
    MELD-Lactate Predicts Poor Outcome in Variceal Bleeding in Cirrhosis.
    Dig Dis Sci. 2022 Nov 14. pii: 10.1007/s10620-022-07744.
    >> Share

  126. CURRAN C, Priest M, Datta S, Forrest EH, et al
    Hepatocellular Carcinoma Risk Scores Predict Patients Under Surveillance at Low Risk of Benefit and High Risk of Harm.
    Dig Dis Sci. 2022 Nov 14. pii: 10.1007/s10620-022-07731.
    >> Share

  127. INOUE T, Kitano R, Ibusuki M, Sakamoto K, et al
    Endoscopic Ultrasound-Guided Hepaticogastrostomy with Antegrade Stenting Without Dilation Device Application for Malignant Distal Biliary Obstruction in Pancreatic Cancer.
    Dig Dis Sci. 2022 Nov 9. pii: 10.1007/s10620-022-07749.
    >> Share

  128. TAPPER EB, Zhao Z, Mazumder N, Parikh ND, et al
    Incidence of, Risk Factors for, and Outcomes After Ascites in a Population-Based Cohort of Older Americans.
    Dig Dis Sci. 2022;67:5327-5335.
    >> Share

  129. SARAIREH H, Abdelfattah T, Hassouneh R, Lippman R, et al
    "Wet Heparin" and "Wet Saline" EUS-Guided Liver Biopsy Techniques Both Provide High Rates of Specimen Adequacy for Benign Parenchymal Liver Disease.
    Dig Dis Sci. 2022;67:5256-5261.
    >> Share

  130. YEBOAH-KORANG A, Memon A, Patel N, Portocarrero-Castillo A, et al
    Impact of Prior Drug Allergies on the Risk, Clinical Features, and Outcomes of Idiosyncratic Drug-Induced Liver Injury in Adults.
    Dig Dis Sci. 2022;67:5262-5271.
    >> Share

  131. CARDOSO AC, Tovo CV, Leite NC, El Bacha IA, et al
    Validation and Performance of FibroScan(R)-AST (FAST) Score on a Brazilian Population with Nonalcoholic Fatty Liver Disease.
    Dig Dis Sci. 2022;67:5272-5279.
    >> Share

    October 2022
  132. LIU YC, Cheng YT, Chen YC, Hsieh YC, et al
    Correction: Comparing Predictability of Noninvasive Tools for Hepatocellular Carcinoma in Treated Chronic Hepatitis C Patients.
    Dig Dis Sci. 2022 Oct 17. pii: 10.1007/s10620-022-07683.
    >> Share

  133. SCHEINBERG AR, John BV
    MAFLD Versus NAFLD: Which Better Predicts the Risk of Atherosclerotic Cardiovascular Disease?
    Dig Dis Sci. 2022;67:4606-4608.
    >> Share

  134. KIM H, Lee CJ, Ahn SH, Lee KS, et al
    MAFLD Predicts the Risk of Cardiovascular Disease Better than NAFLD in Asymptomatic Subjects with Health Check-Ups.
    Dig Dis Sci. 2022;67:4919-4928.
    >> Share

  135. GIRI S, Darak H, Kasturi S
    Benefit of Antiviral Therapy for HBV-Related HCC with Undetectable HBV DNA Is Still Dubious.
    Dig Dis Sci. 2022;67:4962-4964.
    >> Share

  136. ASHOURI Y, Hsu CH, Riall TS, Konstantinidis IT, et al
    Aspartate Aminotransferase-to-Platelet Ratio Index Predicts Liver Failure After Resection of Colorectal Liver Metastases.
    Dig Dis Sci. 2022;67:4950-4958.
    >> Share

    September 2022
  137. KHAKOO NS, Sultan S, Reynolds JM, Levy C, et al
    Efficacy and Safety of Bezafibrate Alone or in Combination with Ursodeoxycholic Acid in Primary Biliary Cholangitis: Systematic Review and Meta-Analysis.
    Dig Dis Sci. 2022 Sep 30. pii: 10.1007/s10620-022-07704.
    >> Share

  138. BENSON M, Gopal D, Pfau P
    Electronic Health Record Work Demands for Gastroenterology and Hepatology Providers: A Prospective Use Analysis and Survey Study.
    Dig Dis Sci. 2022 Sep 28. pii: 10.1007/s10620-022-07691.
    >> Share

  139. SINGH A, De A, Singh MP, Rathi S, et al
    Antibody Response and Safety of ChAdOx1-nCOV (Covishield) in Patients with Cirrhosis: A Cross-Sectional, Observational Study.
    Dig Dis Sci. 2022 Sep 25. pii: 10.1007/s10620-022-07641.
    >> Share

  140. HARTGERINK C, Nimri FM, Zuchelli T, Jafri SM, et al
    Band Ligation Can Be Used to Treat Barrett's Esophagus and Concurrent Esophageal Varices: A Case Series.
    Dig Dis Sci. 2022 Sep 21. pii: 10.1007/s10620-022-07696.
    >> Share

  141. LIU BD, Qureshi K
    Secondary Treatment of Primary Biliary Cholangitis: Early Prediction of Inadequate Response to Ursodeoxycholic Acid in Patients with PBC.
    Dig Dis Sci. 2022 Sep 13. pii: 10.1007/s10620-022-07661.
    >> Share

  142. CHAPIN SE, Goldberg DS, Kaplan DE, Mahmud N, et al
    External Validation of the FIPS Score for Post-TIPS Mortality in a National Veterans Affairs Cohort.
    Dig Dis Sci. 2022;67:4581-4589.
    >> Share

    August 2022
  143. AMES PRJ, D'Andrea G, Arcaro A, Marottoli V, et al
    Liver Cirrhosis Patients Homozygous for MTHFR C677T Develop Portal Vein Thrombosis 8 Years Earlier Than Wild Type.
    Dig Dis Sci. 2022 Aug 24. pii: 10.1007/s10620-022-07666.
    >> Share

  144. CANCADO GGL, Couto CA, Terrabuio DRB, Cancado ELR, et al
    Response to Ursodeoxycholic Acid May Be Assessed Earlier to Allow Second-Line Therapy in Patients with Unresponsive Primary Biliary Cholangitis.
    Dig Dis Sci. 2022 Aug 22. pii: 10.1007/s10620-022-07654.
    >> Share

  145. PREMKUMAR M, Mehtani R, Kulkarni AV, Duseja AK, et al
    Association of Heparin-Like Effect, Factor VII/XIII Deficiency and Fibrinolysis with Rebleeding Risk in Cirrhosis with Acute Variceal Bleeding.
    Dig Dis Sci. 2022 Aug 19. pii: 10.1007/s10620-022-07656.
    >> Share

  146. FERREIRA RD, John BV
    Viral Vector Vaccines Are Victorious Against COVID-19 in Patients with Cirrhosis.
    Dig Dis Sci. 2022 Aug 10. pii: 10.1007/s10620-022-07644.
    >> Share

  147. SAKANO Y, Noda T, Kobayashi S, Kitagawa A, et al
    Clinical Significance of Acylphosphatase 1 Expression in Combined HCC-iCCA, HCC, and iCCA.
    Dig Dis Sci. 2022;67:3817-3830.
    >> Share

  148. SOBOTKA LA, Esteban J, Volk ML, Elmunzer BJ, et al
    Acute Liver Injury in Patients Hospitalized with COVID-19.
    Dig Dis Sci. 2022;67:4204-4214.
    >> Share

  149. RAJAK S, Raza S, Tewari A, Sinha RA, et al
    Environmental Toxicants and NAFLD: A Neglected yet Significant Relationship.
    Dig Dis Sci. 2022;67:3497-3507.
    >> Share

    July 2022
  150. LIU YC, Cheng YT, Chen YC, Hsieh YC, et al
    Comparing Predictability of Non-invasive Tools for Hepatocellular Carcinoma in Treated Chronic Hepatitis C Patients Characters: 102 (< 120).
    Dig Dis Sci. 2022 Jul 27. pii: 10.1007/s10620-022-07621.
    >> Share

  151. MANDORFER M
    Individualization of HCC and Portal Hypertension Surveillance in Patients with Compensated Advanced Chronic Liver Disease and SVR.
    Dig Dis Sci. 2022 Jul 27. pii: 10.1007/s10620-022-07623.
    >> Share

  152. ADAMS PC
    Hepatocellular Carcinoma in Hemochromatosis: Where or When?
    Dig Dis Sci. 2022 Jul 11. pii: 10.1007/s10620-022-07609.
    >> Share

  153. NATARAJAN Y, Patel P, Chu J, Yu X, et al
    Risk of Hepatocellular Carcinoma in Patients with Various HFE Genotypes.
    Dig Dis Sci. 2022 Jul 5. pii: 10.1007/s10620-022-07602.
    >> Share

  154. IZZY M, VanWagner LB
    Analyzing the Different Prevalence for Cirrhotic Cardiomyopathy in Different Studies.
    Dig Dis Sci. 2022 Jul 5. pii: 10.1007/s10620-022-07580.
    >> Share

  155. YARRA P, Dunn W, Younossi Z, Kuo YF, et al
    Association of Previous Gastric Bypass Surgery and Patient Outcomes in Alcohol-Associated Cirrhosis Hospitalizations.
    Dig Dis Sci. 2022 Jul 4. pii: 10.1007/s10620-022-07591.
    >> Share

  156. RAMAI D, Facciorusso A, Singh J, Brooks OW, et al
    Endoscopic Management of Ampullary Adenomas in Familial Adenomatous Polyposis Syndrome: A Systematic Review with Pooled Analysis.
    Dig Dis Sci. 2022;67:3220-3227.
    >> Share

  157. ELFEKI MA, Robles J, Akhtar Z, Ullah F, et al
    Impact of Fibrosis-4 Index Prior to COVID-19 on Outcomes in Patients at Risk of Non-alcoholic Fatty Liver Disease.
    Dig Dis Sci. 2022;67:3333-3339.
    >> Share

  158. FUNG BM, Leon DJ, Beck LN, Tabibian JH, et al
    Pre-procedural Preparation and Sedation for Gastrointestinal Endoscopy in Patients with Advanced Liver Disease.
    Dig Dis Sci. 2022;67:2739-2753.
    >> Share

  159. GARCIA CC, Piotrkowski B, Baz P, Poncino D, et al
    A Decreased Response to Resistin in Mononuclear Leukocytes Contributes to Oxidative Stress in Nonalcoholic Fatty Liver Disease.
    Dig Dis Sci. 2022;67:3006-3016.
    >> Share

  160. THOMAIDES-BREARS HB, Alkhouri N, Allende D, Harisinghani M, et al
    Incidence of Complications from Percutaneous Biopsy in Chronic Liver Disease: A Systematic Review and Meta-Analysis.
    Dig Dis Sci. 2022;67:3366-3394.
    >> Share

    June 2022
  161. DIJOSEPH K, Thorp A, Harrington A, Schmitz KH, et al
    Physical Activity and Risk of Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.
    Dig Dis Sci. 2022 Jun 29. pii: 10.1007/s10620-022-07601.
    >> Share

  162. VIJAYARAGHAVAN R, Sarin SK, Bharadwaj A, Anand L, et al
    Intragastric Balloon in Obese Compensated Nonalcoholic Steatohepatitis Cirrhosis Patients Is Safe and Achieves Significant Weight Reduction at 6-Months.
    Dig Dis Sci. 2022 Jun 28. pii: 10.1007/s10620-022-07596.
    >> Share

  163. CHU J, Cholankeril G, Yu X, Rana A, et al
    Clinical Course and Outcomes of Patients with Nonalcoholic Fatty Liver Disease-Related Hepatocellular Cancer (NAFLD-HCC).
    Dig Dis Sci. 2022 Jun 27. pii: 10.1007/s10620-022-07565.
    >> Share

  164. MAYO MJ, Carey E, Smith HT, Mospan AR, et al
    Impact of Pruritus on Quality of Life and Current Treatment Patterns in Patients with Primary Biliary Cholangitis.
    Dig Dis Sci. 2022 Jun 15. pii: 10.1007/s10620-022-07581.
    >> Share

  165. OHNO A, Fujimori N, Kaku T, Takamatsu Y, et al
    Feasibility and Efficacy of Endoscopic Ultrasound-Guided Hepaticogastrostomy Without Dilation: A Propensity Score Matching Analysis.
    Dig Dis Sci. 2022 Jun 10. pii: 10.1007/s10620-022-07555.
    >> Share

  166. DHIR V, Bale A
    EUS-Guided Hepatico-Gastrostomy: To Dilate or Not to Dilate?
    Dig Dis Sci. 2022 Jun 10. pii: 10.1007/s10620-022-07560.
    >> Share

  167. KUGELMAS M, Zapata I, Tawil J, Pessetto A, et al
    Liver Cirrhosis Increases the Risk of Developing Advanced Colon Polyps.
    Dig Dis Sci. 2022 Jun 7. pii: 10.1007/s10620-022-07561.
    >> Share

  168. PAN AY, Zilberstein NF, Farnan JM, McConville JF, et al
    Recently Graduated Medical Students Lack Exposure to and Comfort with Chronic Liver Diseases.
    Dig Dis Sci. 2022;67:2081-2085.
    >> Share

  169. TESTINO G, Vignoli T, Patussi V, Allosio P, et al
    Alcohol-Related Liver Disease in the Covid-19 Era: Position Paper of the Italian Society on Alcohol (SIA).
    Dig Dis Sci. 2022;67:1975-1986.
    >> Share

  170. GLASS L, Asefa H, Volk M, Lok AS, et al
    Disease Knowledge, Health-Related Quality of Life, and Lifestyle Behavior Change in Patients with Nonalcoholic Fatty Liver Disease: Impact of an Educational Intervention.
    Dig Dis Sci. 2022;67:2123-2133.
    >> Share

  171. NABI O, Boursier J, Lacombe K, Mathurin P, et al
    Comorbidities Are Associated with Fibrosis in NAFLD Subjects: A Nationwide Study (NASH-CO Study).
    Dig Dis Sci. 2022;67:2584-2593.
    >> Share

  172. SIDDIQUI MA, Suresh S, Simmer S, Abu-Ghanimeh M, et al
    Increased Morbidity and Mortality in COVID-19 Patients with Liver Injury.
    Dig Dis Sci. 2022;67:2577-2583.
    >> Share

    May 2022
  173. ASOTIBE JC, Banini BA
    Hepatic Hydrothorax: An Independent Predictor of Mortality in Cirrhosis? Is the MELD-Na Score Worth Its Salt?
    Dig Dis Sci. 2022 May 9. pii: 10.1007/s10620-022-07523.
    >> Share

  174. OSMAN KT, Abdelfattah AM, Mahmood SK, Elkhabiry L, et al
    Refractory Hepatic Hydrothorax Is an Independent Predictor of Mortality When Compared to Refractory Ascites.
    Dig Dis Sci. 2022 May 9. pii: 10.1007/s10620-022-07522.
    >> Share

  175. AL-OBAID LN, Bazarbashi AN, Ryou M
    Variceal Bleeding: Beyond Banding.
    Dig Dis Sci. 2022;67:1442-1454.
    >> Share

    April 2022
  176. B HADI Y, Khan RS, Lakhani DA, Khan AY, et al
    Antibiotic Prophylaxis for Upper Gastrointestinal Bleed in Liver Cirrhosis; Less May Be More.
    Dig Dis Sci. 2022 Apr 25. pii: 10.1007/s10620-022-07481.
    >> Share

  177. ZHAO M, Ma L, Honda T, Kato A, et al
    Astaxanthin Attenuates Nonalcoholic Steatohepatitis with Downregulation of Osteoprotegerin in Ovariectomized Mice Fed Choline-Deficient High-Fat Diet.
    Dig Dis Sci. 2022 Apr 10. pii: 10.1007/s10620-022-07489.
    >> Share

  178. NOBARANI S, Alaei-Shahmiri F, Aghili R, Malek M, et al
    Visceral Adipose Tissue and Non-alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes.
    Dig Dis Sci. 2022;67:1389-1398.
    >> Share

  179. NOUREDDIN N, Noureddin M, Singh A, Alkhouri N, et al
    Progression of Nonalcoholic Fatty Liver Disease-Associated Fibrosis in a Large Cohort of Patients with Type 2 Diabetes.
    Dig Dis Sci. 2022;67:1379-1388.
    >> Share

    March 2022
  180. TAKIGAWA A, Sakamori R, Tahata Y, Yoshioka T, et al
    Prediction Model for Intrahepatic Distant Recurrence After Radiofrequency Ablation for Primary Hepatocellular Carcinoma 2 cm or Smaller.
    Dig Dis Sci. 2022 Mar 30. pii: 10.1007/s10620-022-07455.
    >> Share

  181. HENSON JB, Helzberg JH, Muir AJ
    Patient-Predicted Outcomes Are Associated with Quality of Life in Patients with Primary Sclerosing Cholangitis.
    Dig Dis Sci. 2022 Mar 28. pii: 10.1007/s10620-022-07482.
    >> Share

  182. BUCSICS T, Lampichler K, Vierziger C, Schoder M, et al
    Covered Transjugular Intrahepatic Portosystemic Shunt Improves Hypersplenism-Associated Cytopenia in Cirrhosis.
    Dig Dis Sci. 2022 Mar 17. pii: 10.1007/s10620-022-07443.
    >> Share

  183. RAMANI A, Tapper EB, Griffin C, Shankar N, et al
    Hepatocellular Carcinoma-Related Mortality in the USA, 1999-2018.
    Dig Dis Sci. 2022 Mar 14. pii: 10.1007/s10620-022-07433.
    >> Share

  184. SINHA A, Bhuva M, Grant C, Gimson AE, et al
    ABCB4 Mutations in Adults Cause a Spectrum Cholestatic Disorder Histologically Distinct from Other Biliary Disease.
    Dig Dis Sci. 2022 Mar 14. pii: 10.1007/s10620-022-07416.
    >> Share

  185. CHOI AY, Chang KJ, Samarasena JB, Lee JG, et al
    Endoscopic Ultrasound-Guided Porto-systemic Pressure Gradient Measurement Correlates with Histological Hepatic Fibrosis.
    Dig Dis Sci. 2022 Mar 12. pii: 10.1007/s10620-022-07418.
    >> Share

  186. LEE TH, Hirshman N, Cardona DM, Berg CL, et al
    LR-3 and LR-4 Lesions Are More Likely to Be Hepatocellular Carcinoma in Transplant Patients with LR-5 or LR-TR Lesions.
    Dig Dis Sci. 2022 Mar 7. pii: 10.1007/s10620-022-07428.
    >> Share

  187. ZHAO Z, Gao J, Huang S
    LncRNA SNHG7 Promotes the HCC Progression Through miR-122-5p/FOXK2 Axis.
    Dig Dis Sci. 2022;67:925-935.
    >> Share

  188. BHURWAL A, Makar M, Patel A, Mutneja H, et al
    Safety and Efficacy of Thrombin for Bleeding Gastric Varices: A Systematic Review and Meta-Analysis.
    Dig Dis Sci. 2022;67:953-963.
    >> Share

    February 2022
  189. DIBATTISTA JV, Burkholder DA, Lok AS, Chen VL, et al
    Accuracy of Non-invasive Indices for Diagnosing Hepatic Steatosis Compared to Imaging in a Real-World Cohort.
    Dig Dis Sci. 2022 Feb 15. pii: 10.1007/s10620-022-07415.
    >> Share

  190. SINGH AD, Ford A, Lyu R, Layoun H, et al
    Impact of Cirrhotic Cardiomyopathy Diagnosed According to Different Criteria on Patients with Cirrhosis Awaiting Liver Transplantation: A Retrospective Cohort Study.
    Dig Dis Sci. 2022 Feb 12. pii: 10.1007/s10620-022-07412.
    >> Share

  191. ROGAL SS, Chinman MJ, DeMonte W, Gibson S, et al
    Using Intervention Mapping to Develop a Novel Pain Self-Management Intervention for People with Cirrhosis.
    Dig Dis Sci. 2022 Feb 11. pii: 10.1007/s10620-022-07380.
    >> Share

  192. SHENOY A, Louissaint J, Shannon C, Tapper EB, et al
    Viscoelastic Testing Prior to Non-surgical Procedures Reduces Blood Product Use Without Increasing Bleeding Risk in Cirrhosis.
    Dig Dis Sci. 2022 Feb 5. pii: 10.1007/s10620-021-07376.
    >> Share

  193. JINDAL A, Sarin SK, Kumar M, Kumar G, et al
    Clinical Outcomes in Patients with Advanced Chronic Liver Disease and Hepatic Venous Pressure Gradient
    Dig Dis Sci. 2022 Feb 3. pii: 10.1007/s10620-021-07334.
    >> Share

  194. GIBBS JT, Louissaint J, Tapper EB
    Rate of Successful Extubation in Mechanically Ventilated Patients with Cirrhosis and Hepatic Coma.
    Dig Dis Sci. 2022 Feb 2. pii: 10.1007/s10620-022-07400.
    >> Share

  195. FAUST A, Stine JG
    Time to Step It Up: Mobile Health Intervention for Lifestyle Modification in Patients with Nonalcoholic Fatty Liver Disease.
    Dig Dis Sci. 2022;67:403-405.
    >> Share

  196. CHAUHAN M, Singh K, Thuluvath PJ
    Bariatric Surgery in NAFLD.
    Dig Dis Sci. 2022;67:408-422.
    >> Share

  197. TINCOPA MA, Lyden A, Wong J, Jackson EA, et al
    Impact of a Pilot Structured Mobile Technology Based Lifestyle Intervention for Patients with Nonalcoholic Fatty Liver Disease.
    Dig Dis Sci. 2022;67:481-491.
    >> Share

  198. LI Y, Chen C, Lu L, Guo W, et al
    Cadmium Exposure in Young Adulthood Is Associated with Risk of Nonalcoholic Fatty Liver Disease in Midlife.
    Dig Dis Sci. 2022;67:689-696.
    >> Share

    January 2022
  199. GONZALEZ JJ, Dziwis J, Patel YA, Tapper EB, et al
    Identifying Ascites in Patients with Cirrhosis Using Administrative Codes and Diuretic Use: A Multicenter Study.
    Dig Dis Sci. 2022 Jan 28. pii: 10.1007/s10620-021-07367.
    >> Share

  200. PARK MK, Lee YB, Moon H, Choi NR, et al
    Effectiveness of Lenvatinib Versus Sorafenib for Unresectable Hepatocellular Carcinoma in Patients with Hepatic Decompensation.
    Dig Dis Sci. 2022 Jan 20. pii: 10.1007/s10620-021-07365.
    >> Share

  201. PANCHAL SA, Kaplan DE, Goldberg DS, Mahmud N, et al
    Algorithms to Identify Alcoholic Hepatitis Hospitalizations in Patients with Cirrhosis.
    Dig Dis Sci. 2022 Jan 13. pii: 10.1007/s10620-021-07321.
    >> Share

  202. CHANDAN S, Deliwala S, Khan SR, Ramai D, et al
    Advanced Endoscopic Resection Techniques in Cirrhosis-A Systematic Review and Meta-Analysis of Outcomes.
    Dig Dis Sci. 2022 Jan 6. pii: 10.1007/s10620-021-07364.
    >> Share

  203. WEGERMANN K, Wilder JM, Parish A, Niedzwiecki D, et al
    Racial and Socioeconomic Disparities in Utilization of Telehealth in Patients with Liver Disease During COVID-19.
    Dig Dis Sci. 2022;67:93-99.
    >> Share

  204. WAHID N, Rosenblatt R
    Disparities in Telehealth for Liver Disease: Revealing What Was Hidden in Plain Sight.
    Dig Dis Sci. 2022;67:3-5.
    >> Share

  205. NAJAFIAN N, Weber AT, Zuckerman JE, Zhang S, et al
    AL Lambda Amyloidosis Activates Acute Liver Failure in the Absence of Plasma Cell Dyscrasia.
    Dig Dis Sci. 2022;67:67-70.
    >> Share

  206. KHALIFA A, Sasso R, Rockey DC
    Role of Liver Biopsy in Assessment of Radiologically Identified Liver Masses.
    Dig Dis Sci. 2022;67:337-343.
    >> Share

  207. WANGRATTANAPRANEE P, Khrucharoen U, Jensen DM, Wongpongsalee T, et al
    Severe Upper Gastrointestinal Hemorrhage Caused by Reflux Esophagitis.
    Dig Dis Sci. 2022;67:159-169.
    >> Share

    December 2021
  208. JOHNSON KD, Perisetti A, Goyal H, Thandassery R, et al
    Liver Biopsy in Pregnancy: Two Case Reports and Review of the Literature.
    Dig Dis Sci. 2021;66:4090-4098.
    >> Share

  209. YAN Y, Xing X, Wang X, Men R, et al
    Development and Validation of an Easy-to-Use Risk Scoring System for Screening High-Risk Varices in Patients with HBV-Related Compensated Advanced Chronic Liver Disease.
    Dig Dis Sci. 2021;66:4518-4524.
    >> Share

  210. HIGUERA-DE-LA-TIJERA F, Cordova-Gallardo J, Buganza-Torio E, Barranco-Fragoso B, et al
    Hepamet Fibrosis Score in Nonalcoholic Fatty Liver Disease Patients in Mexico: Lower than Expected Positive Predictive Value.
    Dig Dis Sci. 2021;66:4501-4507.
    >> Share

  211. DHALIWAL HS, Singh R, Abraham AM, Sharma R, et al
    Perception of Illness and Its Association with Treatment Willingness in Patients with Newly Diagnosed Nonalcoholic Fatty Liver Disease.
    Dig Dis Sci. 2021;66:4197-4207.
    >> Share

    November 2021
  212. CHANG JI, Sinn DH, Cho H, Kim S, et al
    Clinical Outcomes of Hepatitis B Virus-Related Hepatocellular Carcinoma Patients with Undetectable Serum HBV DNA Levels.
    Dig Dis Sci. 2021 Nov 20. pii: 10.1007/s10620-021-07312.
    >> Share

  213. DONG TS, Jacobs JP, Agopian V, Pisegna JR, et al
    Duodenal Microbiome and Serum Metabolites Predict Hepatocellular Carcinoma in a Multicenter Cohort of Patients with Cirrhosis.
    Dig Dis Sci. 2021 Nov 20. pii: 10.1007/s10620-021-07299.
    >> Share

  214. PODRUG K, Trkulja V, Zelenika M, Bokun T, et al
    Validation of the New Diagnostic Criteria for Clinically Significant Portal Hypertension by Platelets and Elastography.
    Dig Dis Sci. 2021 Nov 5. pii: 10.1007/s10620-021-07277.
    >> Share

  215. BENITEZ C
    Pressure Measurements Under Pressure: Simplifying the Diagnosis of Clinically Significant Portal Hypertension.
    Dig Dis Sci. 2021 Nov 5. pii: 10.1007/s10620-021-07283.
    >> Share

  216. MANKA PP, Kaya E, Canbay A, Syn WK, et al
    A Review of the Epidemiology, Pathophysiology, and Efficacy of Anti-diabetic Drugs Used in the Treatment of Nonalcoholic Fatty Liver Disease.
    Dig Dis Sci. 2021;66:3676-3688.
    >> Share

  217. KOSICK HM, Keyrouz A, Adeyi O, Sebastiani G, et al
    A Stepwise Algorithmic Approach and External Validation Study for Noninvasive Prediction of Advanced Fibrosis in Nonalcoholic Fatty Liver Disease.
    Dig Dis Sci. 2021;66:4046-4057.
    >> Share

  218. ABDU B, Akolkar S, Picking C, Boura J, et al
    Factors Associated with Delayed Paracentesis in Patients with Spontaneous Bacterial Peritonitis.
    Dig Dis Sci. 2021;66:4035-4045.
    >> Share

    October 2021
  219. BURKHOLDER DA, Moran IJ, DiBattista JV, Lok AS, et al
    Accuracy of International Classification of Diseases-10 Codes for Cirrhosis and Portal Hypertensive Complications.
    Dig Dis Sci. 2021 Oct 21. pii: 10.1007/s10620-021-07282.
    >> Share

  220. LI W, Xue H, Li Y, Li P, et al
    HIPK3 Circular RNA Promotes Metastases of HCC Through Sponging miR-338-3p to Induce ZEB2 Expression.
    Dig Dis Sci. 2021;66:3439-3447.
    >> Share

  221. STINE JG, Soriano C, Schreibman I, Rivas G, et al
    Breaking Down Barriers to Physical Activity in Patients with Nonalcoholic Fatty Liver Disease.
    Dig Dis Sci. 2021;66:3604-3611.
    >> Share

    September 2021
  222. KONG J, Liang X, Zhang J, Zeng J, et al
    Antiviral Therapy Improves Survival in Hepatocellular Carcinoma with Microvascular Invasion: A Propensity Score Analysis.
    Dig Dis Sci. 2021 Sep 14. pii: 10.1007/s10620-021-07248.
    >> Share

  223. LI J, Lu M, Zhou Y, Bowlus CL, et al
    Dynamic Risk Prediction of Response to Ursodeoxycholic Acid Among Patients with Primary Biliary Cholangitis in the USA.
    Dig Dis Sci. 2021 Sep 9. pii: 10.1007/s10620-021-07219.
    >> Share

  224. JEON Y, Limketkai BN
    Arrested Development: Slow Progression of Fibrosis in Patients with NAFLD and IBD.
    Dig Dis Sci. 2021;66:2853-2854.
    >> Share

  225. LABENZ C, Kostev K, Kaps L, Galle PR, et al
    Incident Dementia in Elderly Patients with Nonalcoholic Fatty Liver Disease in Germany.
    Dig Dis Sci. 2021;66:3179-3185.
    >> Share

  226. UFERE NN, Donlan J, Indriolo T, Richter J, et al
    Burdensome Transitions of Care for Patients with End-Stage Liver Disease and Their Caregivers.
    Dig Dis Sci. 2021;66:2942-2955.
    >> Share

    August 2021
  227. YOPES MC, Mozeika AM, Liebling S, Haslam A, et al
    An Analysis of 5 Years of Randomized Trials in Gastroenterology and Hepatology Reveals 52 Medical Reversals.
    Dig Dis Sci. 2021 Aug 31. pii: 10.1007/s10620-021-07199.
    >> Share

  228. HANSEN L, Chang MF, Hiatt S, Dieckmann NF, et al
    Symptom Frequency and Distress Underestimated in Decompensated Cirrhosis.
    Dig Dis Sci. 2021 Aug 27. pii: 10.1007/s10620-021-07216.
    >> Share

  229. LOUISSAINT J, Kassab I, Yeboah-Korang A, Fontana RJ, et al
    Combining K-72 Hepatic Failure with 15 Individual T-Codes to Identify Patients with Idiosyncratic Drug-Induced Liver Injury in the Electronic Medical Record.
    Dig Dis Sci. 2021 Aug 24. pii: 10.1007/s10620-021-07223.
    >> Share

  230. TRIVEDI HD, Niezen S, Jiang ZG, Tapper EB, et al
    Severe Hepatic Steatosis by Controlled Attenuation Parameter Predicts Quality of Life Independent of Fibrosis.
    Dig Dis Sci. 2021 Aug 21. pii: 10.1007/s10620-021-07228.
    >> Share

  231. VIJAYARAGHAVAN R, Maiwall R, Arora V, Choudhary A, et al
    Reversal of Feed Intolerance by Prokinetics Improves Survival in Critically Ill Cirrhosis Patients.
    Dig Dis Sci. 2021 Aug 14. pii: 10.1007/s10620-021-07185.
    >> Share

  232. ZHANG S, Tao X, Wang L, Chen H, et al
    Downregulation of Programmed Death-1 Pathway Promoting CD8 + T Cell Cytotoxicity in Primary Biliary Cholangitis.
    Dig Dis Sci. 2021 Aug 14. pii: 10.1007/s10620-021-07165.
    >> Share

  233. CHEN Y, Li H, Chen D, Jiang X, et al
    Hypoxic Hepatocellular Carcinoma Cells Acquire Arsenic Trioxide Resistance by Upregulating HIF-1alpha Expression.
    Dig Dis Sci. 2021 Aug 12. pii: 10.1007/s10620-021-07202.
    >> Share

  234. THAKER S, Mikolajczyk AE
    Concise Commentary: Are We Making a Difference? The Impact of Inpatient Gastroenterology and Hepatology Consultations for Cirrhotic Patients.
    Dig Dis Sci. 2021 Aug 10. pii: 10.1007/s10620-021-07171.
    >> Share

  235. SERPER M, Kaplan DE, Lin M, Taddei TH, et al
    Inpatient Gastroenterology Consultation and Outcomes of Cirrhosis-Related Hospitalizations in Two Large National Cohorts.
    Dig Dis Sci. 2021 Aug 10. pii: 10.1007/s10620-021-07150.
    >> Share

  236. OH JH, Goh MJ, Park Y, Kim J, et al
    Different Performance of Liver Stiffness Measurement According to Etiology and Outcome for the Prediction of Liver-Related Events.
    Dig Dis Sci. 2021;66:2816-2825.
    >> Share

  237. NOZAWA H, Emoto S, Sonoda H, Kawai K, et al
    Liver Injury Among Japanese Patients Treated Using Prophylactic Enoxaparin After Colorectal Surgery.
    Dig Dis Sci. 2021;66:2805-2815.
    >> Share

    July 2021
  238. BOCKORNY B, Bullock AJ, Abrams TA, Faintuch S, et al
    Priming of Sorafenib Prior to Radiofrequency Ablation Does Not Increase Treatment Effect in Hepatocellular Carcinoma.
    Dig Dis Sci. 2021 Jul 23. pii: 10.1007/s10620-021-07156.
    >> Share

  239. CULLARO G, Rubin JB, Fortune BE, Crawford CV, et al
    Association Between Kidney Dysfunction Types and Mortality Among Hospitalized Patients with Cirrhosis.
    Dig Dis Sci. 2021 Jul 22. pii: 10.1007/s10620-021-07159.
    >> Share

  240. HAI Y, Chong W, Eisenbrey JR, Forsberg F, et al
    Network Meta-Analysis: Noninvasive Imaging Modalities for Identifying Clinically Significant Portal Hypertension.
    Dig Dis Sci. 2021 Jul 17. pii: 10.1007/s10620-021-07168.
    >> Share

  241. BARNES EL, Grimm-Vavlitis JL, Long MD
    Impact of Virtual Interviews on Gastroenterology and Hepatology Fellowship Recruitment.
    Dig Dis Sci. 2021 Jul 15. pii: 10.1007/s10620-021-07123.
    >> Share

  242. LIU J, He X, Zou Y, Wang K, et al
    Circular RNA Circ-STIL Contributes to Cell Growth and Metastasis in Hepatocellular Carcinoma via Regulating miR-345-5p/AQP3 Axis.
    Dig Dis Sci. 2021 Jul 6. pii: 10.1007/s10620-021-07054.
    >> Share

  243. MANKA P, Syn WK
    NASH, Metabolic Syndrome, and Diabetes: How Sugar and Fat Increase the Risk of Developing Advanced Liver Disease.
    Dig Dis Sci. 2021;66:2147-2148.
    >> Share

  244. BOPPANA V, Sahni S, Glass J, Chang C, et al
    HCC You Cannot See.
    Dig Dis Sci. 2021;66:2185-2189.
    >> Share

  245. MARTIN M, Zou B, Hoang J, Jeong D, et al
    Racial and Socioeconomic Disparities in Hospitalization of Pediatrics with Liver Disease from 2005 to 2015.
    Dig Dis Sci. 2021;66:2240-2249.
    >> Share

    June 2021
  246. DELEURAN T, Watson H, Vilstrup H, Jepsen P, et al
    Risk Factors for Hepatic Hydrothorax in Cirrhosis Patients with Ascites - A Clinical Cohort Study.
    Dig Dis Sci. 2021 Jun 30. pii: 10.1007/s10620-021-07134.
    >> Share

  247. CHAUHAN M, Zhang T, Thuluvath PJ
    Gender Differences in Liver Transplantation Outcomes in Polycystic Liver Disease.
    Dig Dis Sci. 2021 Jun 30. pii: 10.1007/s10620-021-07125.
    >> Share

  248. CANCADO GGL, Braga MH, Ferraz MLG, Villela-Nogueira CA, et al
    Anti-mitochondrial Antibody-Negative Primary Biliary Cholangitis Is Part of the Same Spectrum of Classical Primary Biliary Cholangitis.
    Dig Dis Sci. 2021 Jun 28. pii: 10.1007/s10620-021-07122.
    >> Share

  249. ZHOU K, Dodge JL, Yuan L, Terrault NA, et al
    Metabolic Risk Profiles for Hepatic Steatosis Differ by Race/Ethnicity: An Elastography-Based Study of US Adults.
    Dig Dis Sci. 2021 Jun 26. pii: 10.1007/s10620-021-07124.
    >> Share

  250. FRENETTE CT, Levy C, Saab S
    Hepatic Encephalopathy-Related Hospitalizations in Cirrhosis: Transition of Care and Closing the Revolving Door.
    Dig Dis Sci. 2021 Jun 24. pii: 10.1007/s10620-021-07075.
    >> Share

  251. HA NB, Cho SJ, Mohamad Y, Kent D, et al
    Visceral Adipose Tissue Inflammation and Radiographic Visceral-to-Subcutaneous Adipose Tissue Ratio in Patients with Cirrhosis.
    Dig Dis Sci. 2021 Jun 16. pii: 10.1007/s10620-021-07099.
    >> Share

  252. DAHIYA M, Eboreime E, Hyde A, Rahman S, et al
    International Classification of Diseases Codes are Useful in Identifying Cirrhosis in Administrative Databases.
    Dig Dis Sci. 2021 Jun 6. pii: 10.1007/s10620-021-07076.
    >> Share

  253. ZOU B, Yeo YH, Cheung R, Ingelsson E, et al
    Fatty Liver Index and Development of Cardiovascular Disease: Findings from the UK Biobank.
    Dig Dis Sci. 2021;66:2092-2100.
    >> Share

  254. SHARMA A, Keshava SN, Eapen A, Elias E, et al
    An Update on the Management of Budd-Chiari Syndrome.
    Dig Dis Sci. 2021;66:1780-1790.
    >> Share

    May 2021
  255. PENG X, Tian A, Li J, Mao Y, et al
    Diagnostic Value of FibroTouch and Non-invasive Fibrosis Indexes in Hepatic Fibrosis with Different Aetiologies.
    Dig Dis Sci. 2021 May 31. pii: 10.1007/s10620-021-07049.
    >> Share

  256. CACCAMO G, Franze MS, Saffioti F, Pitrone C, et al
    Cirrhotic Patients with Bacterial Infection and Negative Cultures Have a More Advanced Disease and an Increased Short-Term Mortality Rate.
    Dig Dis Sci. 2021 May 26. pii: 10.1007/s10620-021-07047.
    >> Share

  257. PINYOPORNPANISH K, Al-Yaman W, Dasarathy S, Romero-Marrero C, et al
    Hepatocellular Carcinoma in Patients Without Cirrhosis: The Fibrosis Stage Distribution, Characteristics and Survival.
    Dig Dis Sci. 2021 May 23. pii: 10.1007/s10620-021-07048.
    >> Share

  258. LI X, Lv J, Hou L, Guo X, et al
    Circ_0001955 Acts as a miR-646 Sponge to Promote the Proliferation, Metastasis and Angiogenesis of Hepatocellular Carcinoma.
    Dig Dis Sci. 2021 May 22. pii: 10.1007/s10620-021-07053.
    >> Share

  259. SERPER M
    Monitoring for Ascites in Cirrhosis Using Patient-Generated Health Data: No Longer a Remote Possibility.
    Dig Dis Sci. 2021 May 18. pii: 10.1007/s10620-021-07020.
    >> Share

  260. YU B, Zhou S, Liang H, Ye Q, et al
    Development and Validation of a Novel Circulating miRNA-Based Diagnostic Score for Early Detection of Hepatocellular Carcinoma.
    Dig Dis Sci. 2021 May 12. pii: 10.1007/s10620-021-07031.
    >> Share

  261. ARTEEL GE, Singhvi A, Feldman R, Althouse AD, et al
    Coexistent Alcohol-Related Liver Disease and Alcohol-Related Pancreatitis: Analysis of a Large Heath Care System Cohort.
    Dig Dis Sci. 2021 May 7. pii: 10.1007/s10620-021-07010.
    >> Share

  262. BLOOM PP, Ventoso M, Tapper E, Ha J, et al
    A Telemonitoring Intervention for Cirrhotic Ascites Management Is Cost-Saving.
    Dig Dis Sci. 2021 May 6. pii: 10.1007/s10620-021-07013.
    >> Share

  263. TO C, Liu L, Satoskar RS, Thuluvath PJ, et al
    Diabetic Hepatosclerosis in a Woman with Maturity-Onset Diabetes of the Young Type 3.
    Dig Dis Sci. 2021 May 3. pii: 10.1007/s10620-021-07005.
    >> Share

  264. RICH NE, Parvathaneni A, Sen A, Odewole M, et al
    High Neutrophil-Lymphocyte Ratio and Delta Neutrophil-Lymphocyte Ratio Are Associated with Increased Mortality in Patients with Hepatocellular Cancer.
    Dig Dis Sci. 2021 May 3. pii: 10.1007/s10620-021-07001.
    >> Share

  265. HASHIMOTO R, Lee DP, Samarasena JB, Chandan VS, et al
    Comparison of Two Specialized Histology Needles for Endoscopic Ultrasound (EUS)-Guided Liver Biopsy: A Pilot Study.
    Dig Dis Sci. 2021;66:1700-1706.
    >> Share

    April 2021
  266. SCHEWE J, Makeschin MC, Khandoga A, Zhang J, et al
    To Protect Fatty Livers from Ischemia Reperfusion Injury: Role of Ischemic Postconditioning.
    Dig Dis Sci. 2021;66:1349-1359.
    >> Share

  267. TROWELL J, Alukal J, Zhang T, Liu L, et al
    How Good Are Controlled Attenuation Parameter Scores from Fibroscan to Assess Steatosis, NASH, and Fibrosis?
    Dig Dis Sci. 2021;66:1297-1305.
    >> Share

  268. SINGAL AK, Ahmed Z, Axley P, Arora S, et al
    Hospitalizations for Acute on Chronic Liver Failure at Academic Compared to Non-academic Centers Have Higher Mortality.
    Dig Dis Sci. 2021;66:1306-1314.
    >> Share

    February 2021
  269. ZHOU SN, Pan WT, Pan MX, Luo QY, et al
    Comparison of Immune Microenvironment Between Colon and Liver Metastatic Tissue in Colon Cancer Patients with Liver Metastasis.
    Dig Dis Sci. 2021;66:474-482.
    >> Share

  270. PATIDAR KR, Davis BC, Slaven JE, Ghabril MS, et al
    Admission Factor V Predicts Transplant-Free Survival in Acute Liver Failure.
    Dig Dis Sci. 2021;66:619-627.
    >> Share

    January 2021
  271. CAVAZZA A, McPhail MJ
    Absolutely FABulous? FABP-1 in Non-acetaminophen-related Acute Liver Failure.
    Dig Dis Sci. 2021;66:10-11.
    >> Share

  272. ABBASS A, Khalid S, Farooq U, Rakov N, et al
    If DILI Is Suspected, Don't Dally.
    Dig Dis Sci. 2021;66:52-55.
    >> Share

  273. PATEL HK, Saxena R, Rush N, Patel SK, et al
    A Comparative Study of 22G versus 19G Needles for EUS-Guided Biopsies for Parenchymal Liver Disease: Are Thinner Needles Better?
    Dig Dis Sci. 2021;66:238-246.
    >> Share

  274. KARVELLAS CJ, Speiser JL, Tremblay M, Lee WM, et al
    Elevated Serum Liver-Type Fatty Acid Binding Protein Levels in Non-acetaminophen Acute Liver Failure Patients with Organ Dysfunction.
    Dig Dis Sci. 2021;66:273-283.
    >> Share

  275. KIM D, Yoo ER, Li AA, Tighe SP, et al
    Trends in Hospitalizations for Clostridioides difficile Infection in End-Stage Liver Disease, 2005-2014.
    Dig Dis Sci. 2021;66:296-307.
    >> Share

    August 2020
  276. PHAW NA, Dyson JK, Mells G, Jones D, et al
    Understanding Fatigue in Primary Biliary Cholangitis.
    Dig Dis Sci. 2020 Aug 26. pii: 10.1007/s10620-020-06502.
    >> Share

  277. PALERMO A, Gerussi A, Mulinacci G, Invernizzi P, et al
    Identifying Racial Disparities in Primary Biliary Cholangitis Patients: A Step Toward Achieving Equitable Outcomes Among All.
    Dig Dis Sci. 2020 Aug 13. pii: 10.1007/s10620-020-06528.
    >> Share

    July 2020
  278. AMJAD W, Alukal J, Zhang T, Maheshwari A, et al
    Two-Dose Hepatitis B Vaccine (Heplisav-B) Results in Better Seroconversion Than Three-Dose Vaccine (Engerix-B) in Chronic Liver Disease.
    Dig Dis Sci. 2020 Jul 2. pii: 10.1007/s10620-020-06437.
    >> Share

    June 2020
  279. YUE W, Liu Y, Jiang W, Huang J, et al
    Prealbumin and D-dimer as Prognostic Indicators for Rebleeding in Patients with Nonvariceal Upper Gastrointestinal Bleeding.
    Dig Dis Sci. 2020 Jun 24. pii: 10.1007/s10620-020-06420.
    >> Share

  280. ADEJUMO AC, Akhtar DH, Dennis BB, Cholankeril G, et al
    Gender and Racial Differences in Hospitalizations for Primary Biliary Cholangitis in the USA.
    Dig Dis Sci. 2020 Jun 13. pii: 10.1007/s10620-020-06402.
    >> Share

  281. WANG CW, Lebsack A, Sudore RL, Lai JC, et al
    Low Rates of Advance Care Planning (ACP) Discussions Despite Readiness to Engage in ACP Among Liver Transplant Candidates.
    Dig Dis Sci. 2020 Jun 4. pii: 10.1007/s10620-020-06369.
    >> Share

    May 2020
  282. SHROFF H, Rinella ME
    Thanks to CLD for Small Favors: Reduced CVD Risk in Patients Awaiting Liver Transplantation.
    Dig Dis Sci. 2020 May 29. pii: 10.1007/s10620-020-06322.
    >> Share

  283. NAGAOKA K, Ogawa K, Ji C, Cao KY, et al
    Targeting Aspartate Beta-Hydroxylase with the Small Molecule Inhibitor MO-I-1182 Suppresses Cholangiocarcinoma Metastasis.
    Dig Dis Sci. 2020 May 22. pii: 10.1007/s10620-020-06330.
    >> Share

    April 2020
  284. ACHARYA C, White MB, Fagan A, Sterling RK, et al
    Liver Transplant Is Associated with Sustained Improvement in Tandem Gait and Risk of Falls.
    Dig Dis Sci. 2020 Apr 22. pii: 10.1007/s10620-020-06261.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016